Sneezing clinical trials
The registry lists 23 studies for Sneezing across more than 10 countries. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2025-12-17.
Who runs them
AstraZeneca (3) · Faes Farma, S.A. (3) · UCB Pharma (2) · Applied Biological Laboratories Inc (1) · Chiayi Christian Hospital (1) · Church & Dwight Company, Inc. (1) · Afexa Life Sciences Inc (1) · University of Medicine and Pharmacy at Ho Chi Minh City (1)
What is being tested here
Drugs under test in Sneezing studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Levocetirizine | 0 | 0 | 3 |
| Bilastine | 0 | 2 | 3 |
| Budesonide | 0 | 1 | 3 |
| Capsaicin | 0 | 1 | 1 |
| Acetaminophen | 0 | 1 | 1 |
| Dimethindene | 0 | 1 | 1 |
| Phenylephrine | 0 | 1 | 1 |
| Resveratrol | 0 | 1 | 1 |
| COLD-fX | 0 | 0 | 1 |
| Mometasone Furoate | 0 | 1 | 1 |
Drug classes tested here Antihistamines 7 · Corticosteroids 4
Who these studies take
No Sneezing study is recruiting now.
Across all 23 studies, recruiting or not: 52% stop at 75 or younger and 39% at 65; 48% take children; 4% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 23 of 23. search them.
- Laser Posterior Nasal Nerve NeurolysisActive, not recruitingNCT07050992Not applicable1 country
- The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis PopulationCompletedNCT05093478Phase 31 country
- Efficacy and Safety of Auricular Acupressure in Treating Allergic RhinitisCompletedNCT06323304Not applicable1 country
- Alleviation of Common Cold SymptomsCompletedNCT06106880Phase 11 country
- ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)CompletedNCT00160680Phase 41 country
- Pilot Study to Assess Performance and Safety of SULFEX 13081.22 Nasal Spray in Patients With Dry or Irritated NoseStatus unknownNCT05499078Not applicable1 country
- Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic RhinitisCompletedNCT01651871Phase 2
- Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and FluCompletedNCT01448057Phase 31 country
- Effects of AkPharma's Calcium Glycerophosphate Nasal Spray WashCompletedNCT01647633Phase 1/21 country
- Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic RhinitisCompletedNCT02130440Phase 31 country
- A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female VolunteersCompletedNCT02109185Phase 1
- LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)CompletedNCT00160589Phase 4
- POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)CompletedNCT00160537Phase 4
- "Anticipatory Guidance in the Nursery and Its Impact on Non-urgent Emergency Department Visits"CompletedNCT01859065Not applicable1 country
- Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal SpraysStatus unknownNCT01702103Phase 31 country
- Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)CompletedNCT01081574Phase 1/23 countries
- Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety ExtensionCompletedNCT01127620Phase 3
- Cyanobacteria Allergy in Lake KineretStatus unknownNCT01693198Not applicable1 country
- A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With BilastineCompletedNCT01108783Phase 3
- Rhinocort Aqua Versus Placebo and Fluticasone PropionateCompletedNCT00641680Phase 3
- New Nasal Applicator / New Formulation - User StudyCompletedNCT00641979Phase 2
- Assess the Efficacy and Safety of Rhinocort AquaCompletedNCT00641693Phase 2
- A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic RhinitisCompletedNCT00726401Phase 21 country